Skip to content

Study of the influences of Yokukansan for sleep disturbance in dementia.

Study of the influences of Yokukansan for sleep disturbance in dementia. - Study of the influences of Yokukansan for sleep disturbance in dementia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006251
Enrollment
30
Registered
2011-09-01
Start date
2011-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia

Interventions

TSUMURA Yokukansan Extract Granules

Sponsors

Division of Psychiatry, Department of Clinical Neuroscience, Faculty of Medicine, University of Miyazaki
Lead Sponsor
Psychogeriatric Center, Daigo Hospital Keimei Memorial Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with dementia 2) Patients with sleep disorder behaviors on the SDI 3) Serum potassium level should be in normal range 4) Those who have a caregiver able to provide an independent evaluation of functioning

Exclusion criteria

Exclusion criteria: 1) Patients with sleep disturbance related to the acute sleep disturbance, delirium and depression 2) Presence of severe illness 3) Those who have joined any clinical trial within 3 month 4) Those who are thought inadequate by their doctor.

Design outcomes

Primary

MeasureTime frame
Sleep Disorders Inventory (SDI)

Secondary

MeasureTime frame
Neuropsychiatric Inventory-Q-J (NPI-Q-J) Sleep outcome measured via actigraph

Countries

Japan

Contacts

Public ContactYoshihito Hayashi

Faculty of Medicine, University of Miyazaki Division of Psychiatry, Department of Clinical Neuroscience

0985-85-2969

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026